Mark A. Cervinski, Ph.D.

2006 The University of North Dakota, Grand Forks, ND, United States 
"Mark Cervinski"
Mean distance: (not calculated yet)


Sign in to add mentor
Roxanne A. Vaughan grad student 2006 University of North Dakota
 (Phosphorylation and regulation of the dopamine transporter by psychostimulant substrates and protein -protein interactions.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Shajani-Yi Z, Lee HK, Cervinski MA. (2016) Hyponatremia, Hypokalemia, Hypochloremia, and Other Abnormalities. Clinical Chemistry. 62: 898
Cembrowski GS, Cervinski MA. (2016) Demystifying Reference Sample Quality Control. Clinical Chemistry
Tolan NV, Parnas ML, Baudhuin LM, et al. (2015) "Big Data" in Laboratory Medicine. Clinical Chemistry
Cervinski MA, Lee HK, Martin IW, et al. (2015) A macro-enzyme cause of an isolated increase of alkaline phosphatase. Clinica Chimica Acta; International Journal of Clinical Chemistry. 440: 169-71
Burchard PR, Abou Tayoun AN, Lefferts JA, et al. (2014) Development of a rapid clinical TPMT genotyping assay. Clinical Biochemistry. 47: 126-9
Kelsey DE, Toher JL, Foster MT, et al. (2014) Laboratory validation of a low density lipoprotein apolipoprotein-B assay. Clinical Biochemistry. 47: 211-5
Cervinski MA. (2014) Laboratory analysis of intraosseous blood: bad to the bone? Clinical Chemistry and Laboratory Medicine. 52: e187-9
Cervinski MA, Sam SS, Steinmetz HB, et al. (2014) Validation of interleukin 28B genotyping assay for clinical use. Clinical Biochemistry. 47: 478-80
McCudden CR, Cervinski MA, Grenache DG, et al. (2013) The SYCL toolkit: creating a program within a professional organization for young scientists. Clinical Chemistry. 59: 1416-7
Cervinski MA, Schwab MC, Lefferts JA, et al. (2013) Establishment of a CYP2C19 genotyping assay for clinical use. American Journal of Clinical Pathology. 139: 202-7
See more...